Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

May 08, 2008

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

May 6, 2008

Vitamin D to boost mood in older adults: study
Increasing your vitamin D intake may lead to mood improvements and protect against depression, suggests new research published today.
Read article at nutraingredients.com

May 5, 2008

CoQ10 may cut muscle injuries for athletes
Supplements of co-enzyme Q10 may reduce the occurrence of muscular injuries in athletes, suggests new research from Japan.
Read article at nutraingredients-usa.com

April 28, 2008

Rosehip reduces osteoarthritis pain, says meta-analysis
Extracts from rosehip may reduce pain associated with osteoarthritis by 37 per cent, according to a meta-analysis of randomized controlled trials (RCTs).
Read article at nutraingredients-usa.com

For more natural health news, click here.

See also our 2001-2008 news archive, by clicking here.

Pharma "Business with Disease" News

May 4, 2008

Commonly used medications associated with impaired physical function in older adults
Older adults who take drugs designed to block the neurotransmitter acetylcholine - including common medications for incontinence, high blood pressure and allergies - are more likely to be dependent in one or more activities of daily living and to walk slower, according to new findings from researchers at Wake Forest University School of Medicine and colleagues.
Read article at physorg.com

May 3, 2008

Eli Lilly Funds Medscape, American Psychiatric Association, Harvard, NAMI National
Eli Lilly's report detailing the company's contributions to various health care organization and advocacy groups for the first three months of 2008 is out now--and it's a doozy. Among the top recipients is the American Psychiatric Association, Harvard University's Massachusetts General Hospital psychiatry department, Medscape and the National Alliance on Mental Illness (NAMI).
Read article at furiousseasons.com
Further information: Click here to read the report.

April 30, 2008

Johnson & Johnson Cuts Another 400 Jobs
The healthcare giant yesterday notified employees it will consolidate the sales and marketing operations of two subsidiaries, Ortho Biotech and Centocor, leading to roughly 400 job cuts nationwide, The Star-Ledger of New Jersey reports. The move is a response to the declining sales of its Procrit anemia med, a spokesman tells the paper. Procrit scrips fell sharply last year after the FDA issued new safety warnings, which were also placed on anemia meds sold by Amgen. More recently, an FDA panel recommended that current use should be restricted over concerns the drugs can increase the risk of tumor growth and death.
Read article at pharmalot.com

April 30, 2008

EU launches $3 billion project to boost drug discovery
Europe is launching a 2 billion euros ($3.1 billion) scheme to boost drug discovery in a bid to re-establish itself as the "pharmacy of the world" and close a growing gap with United States and Asia. The Innovative Medicines Initiative, being unveiled in Brussels on Wednesday, offers grants to academic institutes and small companies to research ways of beating bottlenecks in the drug development process.
Read article in the International Herald Tribune
Comment: Almost needless to say, the scheme's main beneficiaries will be multi-trillion dollar drug industry and its shareholders. Consumers, meanwhile, will continue to be harmed and even killed from the side-effects of patented toxic synthetic drug medicines.

April 29, 2008

Studies shed light on risks of common drugs
Two studies provide new evidence of risks associated with drugs commonly used to treat diabetes and osteoporosis, researchers said on Monday. In one study, U.S. researchers found women who took Merck & Co Inc's osteoporosis drug Fosamax, or alendronate sodium, were nearly twice as likely to have a type of abnormal heartbeat known as atrial fibrillation. In another, Swiss researchers found the diabetes drugs Avandia, or rosiglitazone, from GlaxoSmithKline Plc and Actos, or pioglitazone, from Takeda Pharmaceutical Co Ltd can more than double the risk of bone fractures.
Read Reuters news report at yahoo.com

April 29, 2008

Genentech, Biogen Drug Fails As Lupus Treatment
Investors are upset. Rituxan, which is already approved to treat non-Hodgkins lymphoma and rheumatoid arthritis, failed to prompt a response in patients when compared with placebo in a late-stage, 52-week study. Not only that, the drug failed to meet any of its six secondary goals. Genentech and Biogen Idec shares dove on the disclosure.
Read article at pharmalot.com

April 28, 2008

HRT Increases Stroke Risk
No matter when postmenopausal women start hormone replacement therapy (HRT), high doses of the treatment increase their risk of stroke, a new study finds.
Read article in the Washington Post (USA)

April 28, 2008

Pfizer seeks settlement over drugs trial: Nigerian official
KANO, Nigeria (AFP) - US pharmaceuticals company Pfizer Inc. and the Nigerian state of Kano resumed talks aimed at reaching an out-of-court settlement over an alleged illegal drugs trial, an official said Monday. The alleged illegal clinical trial was carried out in 1996 and left 11 children dead and some 180 others with a deformity or handicap. Kano state justice commissioner Aliyu Umar said state government officials met Pfizer representatives last month in the federal capital Abuja, where the drug company made a financial offer which Kano rejected as inadequate.
Read AFP news report at google.com

April 28, 2008

Medical School Group Urges Freebie Ban
Drug and device makers shouldn't be allowed to offer freebies - including meals, gifts, travel and ghost-writing helps - to docs, staffers and students in any or all 129 of the nation's medical colleges, according to a new report from the Association of American Medical Colleges, which spent two years on the project.
Read article at pharmalot.com

For more pharma "business with disease" news, click here.

See also our 2001-2008 news archive, by clicking here.

GMO News

April 30, 2008

Mass Protests against GM Crops in India
India-wide coalition against GM Brinjal in the wake of toxic GM cotton
As India edges closer to what is probably the last year of field trials for Bt Brinjal (eggplant, aubergine) before commercial approval may be granted, large scale resistance has been building up all over the country. Bt Brinjal, if allowed in India, would be the first food crop in the world with the Bt gene inserted into it that is to be directly consumed by human beings. Indians feel that they are about to be made guinea pigs by USAID, and by Monsanto and Cornell University that have developed this crop.
Read press release on the website of the Institute of Science in Society (ISIS) (UK)

For more GMO news, click here.

U.N. - Related News

April 28, 2008

At WHO Meeting, Patient Group Has Pharma Ties
A World Health Organization group that meets in Geneva today to debate ways to improve access to drugs in the developing world and promoting R&D for new meds is, of course, going to attract input from all sides, including industry, academics, patients groups and non-govermental organizations, or NGOs. However, many individuals who signed a "Patient Declaration" have undisclosed ties to pharma, as does the patient advocacy group that is circulating the petition, according to Essential Action, a non-profit project that focuses on public health and corporate accountability, and is funded by the Open Society Institute and the Ford Foundation.
Read article at pharmalot.com

For more U.N. - Related news, click here.

See also our 2001-2008 news archive, by clicking here.

Other Health-related News

April 30, 2008

Europe may ban 120 food nutrients
The European Food Safety Authority (EFSA) has rejected dossiers backing 120 nutrient sources for ongoing use within the European Union because they were deemed "not to be adequate".
Read article at nutraingredients.com
Comment: EFSA's rulings may lead to the removal of nutrients including forms of boron, selenium, magnesium and calcium from supplements. As such, whilst we were accused of scaremongering in 2002 when we said that the passing of the European Union's Food Supplements Directive would lead to some supplements and supplement ingredients being banned completely, this latest development proves once again that we were right all along.
Further information: To read EFSA's press release, click here. To read the statement of EFSA's Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC), upon which EFSA's rejection of these nutrient sources was based, click here.

April 29, 2008

A Too-Good-to-Be-True Nutrient?
Imagine a nutrient that could help prevent cancer, heart disease and tuberculosis, preserve bones, and thwart autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and juvenile diabetes. Sounds too good to be true, doesn't it? But that's the potential now being attributed to Vitamin D, whose usefulness was once thought to be limited to prevention of rickets in children and severe bone loss in adults. Known as the sunshine vitamin because it is produced when the skin is exposed to ultraviolet light, Vitamin D has been garnering increasing attention recently, because of what it may be able to do and because many people appear to be getting too little of it.
Read article in the Washington Post (USA)

April 28, 2008

Beijing-The Codex Food Additives Committee Meeting
Seventeen hours after the tires of my Air China jet settled comfortably onto the runway at Beijing International Airport, I was sitting at the National Health Federation's place in the 40th Session of the Codex Committee on Food Additives (CCFA) week-long meeting at the Asia Hotel in downtown Beijing on Monday morning, April 21st. The weather had not cooperated as it rained incessantly, making available taxis as scarce as condom dispensers in the Vatican. Nor did it help that I could not speak a word of Mandarin Chinese; English, French, and bad German can only get you so far, even in this international city. But, I made it, sliding into NHF's seat in time to hear CCFA Chairman Dr. Junshi Chen's opening remarks.
Read press release on the website of the National Health Federation (NHF) (USA)

April 28, 2008

Organic industry attacks "farcial" and "dictatorial" Euro logo
Leading figures within the UK organic sector have criticized the "farcial" and "dictatorial" situation surrounding the EU's plans to impose mandatory use of a Europe-wide logo on all organic food products. Last month the EU announced it was shelving its original 'Bio' logo after the discount supermarket chain Aldi claimed it was too close to its own organic logo. The Bio logo was meant to have appeared on all organic packs by January 2009. Leading UK certifying bodies and manufacturers have strongly opposed the EU initiative claiming that the word 'Bio' is meaningless to UK consumers and would create unnecessary confusion. Industry also accuses the EU of acting undemocratically and riding roughshod over its concerns.
Read article at Natural Products Online (UK)

For more health-related news, click here.

See also our 2001-2008 news archive, by clicking here.

Political News

May 6, 2008

EU court judgements affecting Irish treaty campaign
The Irish government's official campaign in favour of the EU's Lisbon Treaty has been dealt a blow following the decision by a major union to speak out against the document. The Technical Engineering and Electrical Union on Monday (5 May) urged its 45,000 members to vote against the treaty in the referendum next month. General secretary of the TEEU Eamon Devoy took the stance on the back of recent judgements by the EU's highest court which he said had shown that the pendulum had "swung against workers' rights and in favour of big business.
Read article at euobserver.com
Comment: Ireland is still the only country currently planning to hold a referendum on the treaty, on 12 June.

May 2, 2008

Victory in first round of campaign to force EU treaty referendum
Stuart Wheeler, one of Britain's richest men, has won the first round of his battle to force Gordon Brown to hold a referendum on the EU Reform Treaty. He went to the High Court in London last month to seek a judicial review of the Government's decision not to hold a referendum on the treaty. Today judges ruled that the challenge can go ahead.
Read article in the Daily Telegraph (UK)

April 24, 2008

Czech Senate asks Constitutional Court to examine Lisbon treaty
The Czech Senate today asked the Constitutional Court to examine whether the Lisbon treaty, setting down new rules of the EU, is in harmony with the Czech constitutional order. The proposal, supported by 48 out of the 70 present senators, was initiated by the governing Civic Democratic Party (ODS). Senators for the opposition Social Democrats (CSSD) and the Open Democracy Club tried in vain to have the treaty ratified without any postponements.
Read article at ceskenoviny.cz (Czech Republic)

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website.

Back to the Newsletter Archive…